GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nutra Pharma NPHC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Nutra Pharma — daily NPHC Delayed
Market value
$1.9m
Last close × shares
Volume
2.1m
Shares, 9 Nov 2026

About Nutra Pharma

From its filings with the US Securities and Exchange Commission

SEC filings

Nutra Pharma is based in Boca Raton, Florida and is incorporated in California. Its shares trade on OTC under the ticker NPHC. The SEC classifies its business as medicinal chemicals & botanical products. In the fiscal year to 31 December 2025, it reported revenue of $257,612 and a net loss of $2.0m. At that date it held total assets of $584,558 and shareholders' equity of −$16.8m.

In its own words

Pharma is a biopharmaceutical company with intellectual property for drugs that treat autoimmune disorders, viral diseases and pain.

Nutra Pharma was incorporated under the laws of the state of California on February 1, 2000, under the original name of Exotic-Bird.com.

Since European rules for homeopathic drugs are different than the rules in the US, we cannot estimate when this process will be completed.

June of 2013, we announced the launch of our new homeopathic formula for the treatment of chronic pain in companion animals, Pet Pain–Away.

May of 2016, we signed a license agreement to begin the process of creating an infomercial (Direct Response) campaign for Pet Pain–Away.

In 2023, we moved to our new facility in Boca Raton and have certified our lab for production.

Marketing channel. The arrangement is no longer material to the Company’s current operations.

May of 2016, we signed a license agreement to begin the process of creating an infomercial (Direct Response) campaign for Pet Pain-Away.

In November of 2016, we announced the license agreement with DEG Productions for the marketing and distribution of Pet Pain-Away globally.

Quoted from its 10-K, filed 20 May 2026. Read the filing on SEC.gov ↗

More about Nutra Pharma →

Latest on Nutra Pharma

Our reporting

We have not reported on Nutra Pharma yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Nutra Pharma's ticker?

Nutra Pharma trades as NPHC on its US listing, under ISIN US67060U2087.

What was Nutra Pharma's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.